Synthetic Carbon Capture Organisms are engineered microorganisms designed to hyper-efficiently fix carbon dioxide from the atmosphere, converting it directly into stable biopolymers. These organisms are optimized for the Calvin cycle and incorporate new synthetic metabolic pathways.
Addressing atmospheric CO2 levels and promoting sustainable materials production through biological means.
These organisms are genetically modified to enhance their ability to capture CO2 through the optimization of the Calvin cycle, a process used by plants to convert carbon dioxide into organic compounds. Additionally, they have been engineered with synthetic metabolic pathways that allow them to directly convert captured CO2 into biopolymers, which can be harvested and utilized in various applications.
The manufacturing process involves genetic engineering of microorganisms, typically bacteria or algae, to include synthetic metabolic pathways that enhance their carbon fixation capabilities. These organisms are then cultured under controlled conditions for mass production.
The build process includes gene synthesis and assembly, followed by the integration of these genes into host microorganisms using techniques such as CRISPR-Cas9. The resulting organisms are then tested in laboratory settings before scaling up to industrial-scale operations.
Curated names only — none are invented. Use the link to find more.
Cost drivers only — no verified dollar figures are shown. Check live sources for prices.
Illustrative — search real, dated examples rather than trusting a generated story.
Live searches — we don't list papers we can't verify.
Live patent searches — filings are never listed from memory.
Verify against primary sources only.
Source: curated technology intelligence stream with tracked references.